Startups
QurCan Therapeutics (formerly Nanology Labs Inc) is a biotech company, developing next generation nanomedicine for treatment of hard-to treat, hard-to-reach diseases.
QurCan Therapeutics' drug delivery platform technology enables active and targeted delivery of therapeutic compounds, including mRNAs and siRNAs to various solid tumor tissues, including those in the brain.
QurCan's lead candidate, T-MX, is a first-in-class nanoparticle agent which can turn cold tumors hot via overcoming hypoxia in solid tumors.
QurCan Therapeutics' drug delivery platform technology enables active and targeted delivery of therapeutic compounds, including mRNAs and siRNAs to various solid tumor tissues, including those in the brain.
QurCan's lead candidate, T-MX, is a first-in-class nanoparticle agent which can turn cold tumors hot via overcoming hypoxia in solid tumors.
Overview
Location
Canada, Ontario, Toronto
Employees
1-10
Founded date
2018
FAQ about QurCan Therapeutics Inc.
When was QurCan Therapeutics Inc. founded?
QurCan Therapeutics Inc. was founded in 2018.
Is QurCan Therapeutics Inc. still active?
Yes, QurCan Therapeutics Inc. is active; its latest activity on Parsers VC dates from Sep 15, 2026.